These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 17988
1. Effect of tilorone hydrochloride on graft-versus-host (GvH) reaction in mice. Zschiesche W, Slavina E, Leipunskaya I. Acta Biol Med Ger; 1977; 36(1):107-12. PubMed ID: 17988 [Abstract] [Full Text] [Related]
2. The interferonogenic agent tilorone as a modulator of GvH reaction in mice. Zschiesche W, Slavina E, Leipunskaya I. Arch Immunol Ther Exp (Warsz); 1977; 25(5):725-30. PubMed ID: 23088 [Abstract] [Full Text] [Related]
3. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice. Peres A, Nestel FP, Seemayer TA, Lapp WS. J Immunol; 1986 Dec 01; 137(11):3420-7. PubMed ID: 3537120 [Abstract] [Full Text] [Related]
4. Syngeneic GvH induced in popliteal lymph nodes by spleen cells of old C57BL/6 mice. Gozes Y, Umiel T, Meshorer A, Trainin N. J Immunol; 1978 Dec 01; 121(6):2199-204. PubMed ID: 31401 [Abstract] [Full Text] [Related]
5. Immunomodulation by low-dose methotrexate. I. Methotrexate selectively inhibits Lyt-2+ cells in murine acute graft-versus-host reactions. Gibbons JJ, Lucas J. J Immunol; 1989 Mar 15; 142(6):1867-73. PubMed ID: 2784139 [Abstract] [Full Text] [Related]
6. Defective thymic education of L3T4+ T helper cell function in graft-vs-host mice. Fukuzawa M, Via CS, Shearer GM. J Immunol; 1988 Jul 15; 141(2):430-9. PubMed ID: 2968400 [Abstract] [Full Text] [Related]
7. Activation and suppression of graft-vs-host reactions by cyclophosphamide. Wander RH, Hilgard HR. J Immunol; 1981 Mar 15; 126(3):901-4. PubMed ID: 7462635 [Abstract] [Full Text] [Related]
8. Subpopulations of mouse T lymphocytes. II. Suppression of graft-vs.-host reactions by naturally proliferating splenic T cells. Moorhead JW. Eur J Immunol; 1978 Mar 15; 8(3):163-7. PubMed ID: 26575 [Abstract] [Full Text] [Related]
9. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease. Via CS, Sharrow SO, Shearer GM. J Immunol; 1987 Sep 15; 139(6):1840-9. PubMed ID: 2957440 [Abstract] [Full Text] [Related]
10. In vivo function tests of the effect of tilorone and niridazole on cell-mediated immunity in chickens. Donahoe JP, Giambrone J, Fletcher OJ, Kleven SH. Am J Vet Res; 1977 Dec 15; 38(12):2013-7. PubMed ID: 23063 [Abstract] [Full Text] [Related]
11. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations. Ghayur T, Seemayer TA, Lapp WS. Transplantation; 1987 Aug 15; 44(2):254-60. PubMed ID: 3498241 [Abstract] [Full Text] [Related]
12. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference. Moser M, Sharrow SO, Shearer GM. J Immunol; 1988 Apr 15; 140(8):2600-8. PubMed ID: 3258615 [Abstract] [Full Text] [Related]
13. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems. Schorlemmer HU, Bosslet K, Dickneite G, Lüben G, Sedlacek HH. Behring Inst Mitt; 1984 May 15; (74):157-73. PubMed ID: 6383322 [Abstract] [Full Text] [Related]
14. The effect of tilorone on the local graft-versus-host reaction in rats. Megel H, Raychaudhuri A, Thomas LL. Transplantation; 1976 Jan 15; 21(1):81-3. PubMed ID: 1883 [No Abstract] [Full Text] [Related]
15. The graft-versus-host reaction and immune function. IV. B cell functional defect associated with a depletion of splenic colony-forming units in marrow of graft-versus-host-reactive mice. Seddik M, Seemayer TA, Lapp WS. Transplantation; 1986 Feb 15; 41(2):242-7. PubMed ID: 3511585 [Abstract] [Full Text] [Related]
16. The effects of polyinosinic:polycytidylic acid on the graft-versus-host reaction. III: Increased severity of the reaction with delayed pI:C treatment. Peres A, Amlani S, Kornbluth M, Seemayer TA, Lapp WS. Transplantation; 1989 Jul 15; 48(1):80-4. PubMed ID: 2749889 [Abstract] [Full Text] [Related]
18. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice. Van Rappard-Van Der Veen FM, Radaszkiewicz T, Terraneo L, Gleichmann E. J Immunol; 1983 Jun 15; 130(6):2693-701. PubMed ID: 6602176 [Abstract] [Full Text] [Related]
20. Graft versus leukemia. VIII. Selective reduction in antihost reactivity without loss of antileukemic reactivity by treatment of donor mice with lipopolysaccharide. Truitt RL, Rose WC, Rimm AA, Bortin MM. Exp Hematol; 1978 May 15; 6(5):488-98. PubMed ID: 26584 [Abstract] [Full Text] [Related] Page: [Next] [New Search]